All News

Corpus Christi, TX-CSMG Technologies has received approval from FDA to market the LTC VAD system, a .400 bipolar electrosurgical generator and two disposable sealing instruments. The tissue binding/welding system is intended for use in open general surgical and gynecologic procedures for ligation of vessels and ducts as an alternative to mechanical clamping or suturing. This third-generation bipolar system can be used on vessels up to 7 mm in diameter, ducts up to 2 mm in diameter, and tissue bundles that fit within the jaws' electrodes.

This article shows you how to make the most of referral sources that often get little attention: friends, family, and community connections.

We review a sampling of software and hardware for the office-based practice that can improve the way you practice, increase your efficiency, and enhance your communication with patients.

Delaying decisions about life insurance can result in expensive and unintended tragic consequences.

Varicocele repair supports the hypothesis that this operation may help to restore fertility by reducing oxidant stress.

Being denied payment for PSA tests.

Physician attitudes, actions at odds over preserving fertility in adolescent men with cancer.

Risks of developing melanoma and prostate cancer are increased among those with a diagnosis of male factor infertility.

The prostate cancer biomarker TMPRSS2-ERG is superior to DNA-based assays.

Lymph node-positive prostate cancer is not always indicative of systemic disease.

Radical prostatectomy patients are most likely to use medication for erectile dysfunction after surgery; those who underwent laparoscopic/robotic prostatectomy were most likely to use ED drugs.

The 2008 update of the American Urological Association clinical guidelines for prostate-specific antigen screening will build on the 2000 version while addressing some controversial aspects of screening.

The 20-milligrams per day tamoxifen therapy reduced the severity of androgen deprivation therapy-related symptoms in prostate cancer patients.

Determining androgen receptor activity in castration-resistant prostate cancer may have potential for distinguishing patients who will respond to androgen deprivation from those who will not.

In men with nonmetastatic prostate cancer treated with intermittent androgen deprivation, thalidomide (Thalomid) significantly prolonged progression-free survival compared with placebo.

Intermittent androgen deprivation with a luteinizing hormone-releasing hormone analog causes fewer side effects and preserves quality of life compared with continuous combined androgen ablation, and many patients have prolonged treatment-free intervals.

Proper diagnosis and treatment of posterior urethral defects from pelvc fractures is critical toward preventing incontinence, impotence, and recurrent stricture disease.

This article describes a risk-stratified approach based on a three-zone anatomic layout to the periprostatic neural architecture and a modified athermal robotic technique for better continence and potency outcomes without compromising surgical margin rates.

The value and timing of chemotherapy in patients undergoing cystectomy for clinically localized bladder cancer has long been controversial. There are myriad reasons supporting both neoadjuvant and adjuvant chemotherapies.

Urologist Andrew C. Novick, MD, chairman of the Cleveland Clinic Glickman Urological and Kidney Institute, died Oct. 18 from complications of lymphoma. He was 60.

An algorithm based on near-infrared spectroscopy (NIRS) is able to correctly identify more than 85% of men classified as obstructed, using catheter urodynamics, according to study findings published in the Canadian Journal of Urology (2008; 1515:4241-8).

A profound gap exists in the understanding of physicians about the literacy levels of their patients related to the efficacy of written screening tools, including the International Prostate Symptom Score, researchers from Emory University School of Medicine, Atlanta, reported.

Use of 5-alpha-reductase inhibitors is not associated with increased risk of hip fracture, according to a study published in JAMA (2008; 300:1660-4).

Older and younger patients with renal cancer derive similar benefit from sorafenib (Nexavar) therapy and tolerate the drug equally well, according to a study from the United Kingdom.

Watson Pharmaceuticals has received FDA approval to market silodosin (Rapaflo), an alpha-blocker for the treatment of BPH signs and symptoms.

Elevated serum follicle-stimulating hormone does not predict a lower sperm retrieval rate for men with nonobstructive azoospermia undergoing microdissection tes­ticular sperm extraction, and should not be considered a contraindication for this fertility procedure.

EPCA-2.19, a second, independent epitope of the EPCA-2 protein, offers extremely high sensitivity and specificity results that are almost identical to those obtained for a first published assay using the EPCA-2.22 epitope.

Tubeless percutaneous nephrolithotomy can be performed safely and effectively without preoperative selection, and it appears to be associated with fewer postoperative intracorporeal changes than standard percutaneous nephrolithotomy.